These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33305166)

  • 1. The impact of liver disease on mortality in cystic fibrosis - a systematic review protocol.
    Sasame A; Connolly L; Fitzpatrick E; Stokes D; Bourke B; Rowland M
    HRB Open Res; 2020; 3():44. PubMed ID: 33305166
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of liver disease on mortality in cystic fibrosis-A systematic review.
    Sasame A; Stokes D; Bourke B; Connolly L; Fitzpatrick E; Rowland M
    J Cyst Fibros; 2022 Mar; 21(2):202-211. PubMed ID: 34380590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and genetic risk factors for cystic fibrosis-related liver disease in Egyptian CF children: A single-center experience.
    El-Faramawy A; Nasr SZ; Emam MMSA; Fahmy HMH
    Pediatr Pulmonol; 2024 Feb; 59(2):465-471. PubMed ID: 38038166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic fibrosis-associated liver disease in children.
    Wasuwanich P; Karnsakul W
    Minerva Pediatr; 2020 Oct; 72(5):440-447. PubMed ID: 32418413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural history of cystic fibrosis liver disease a prospective cohort study.
    Rowland M; Drummond J; Connolly L; Daly E; McCormick PA; Bourke B; ;
    J Cyst Fibros; 2023 Nov; 22(6):1054-1061. PubMed ID: 37495468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis-related liver disease is an independent risk factor for mortality and increased health care resource utilization in hospitalized pediatric patients with cystic fibrosis.
    Thavamani A; Umapathi KK; Kutney K; Sferra TJ; Sankararaman S
    Pediatr Pulmonol; 2022 Jul; 57(7):1717-1725. PubMed ID: 35499220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver disease in cystic fibrosis.
    Rowland M; Bourke B
    Curr Opin Pulm Med; 2011 Nov; 17(6):461-6. PubMed ID: 21881510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic fibrosis related liver disease and endocrine considerations.
    Sherwood JS; Ullal J; Kutney K; Hughan KS
    J Clin Transl Endocrinol; 2022 Mar; 27():100283. PubMed ID: 35024343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving detection of cystic fibrosis related liver disease using liver fibrosis assessment tools.
    Scott JA; Jones AM; Jokl E; Gordon-Walker T; Barry PJ; Hanley NA; Piper Hanley K; Athwal VS
    Heliyon; 2023 Nov; 9(11):e21861. PubMed ID: 38053913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic Fibrosis Liver Disease: Know More.
    Al Sinani S; Al-Mulaabed S; Al Naamani K; Sultan R
    Oman Med J; 2019 Nov; 34(6):482-489. PubMed ID: 31745411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis rabbits develop spontaneous hepatobiliary lesions and CF-associated liver disease (CFLD)-like phenotypes.
    Wu Q; Liang X; Hou X; Song Z; Bouhamdan M; Qiu Y; Koike Y; Rajagopalan C; Wei HG; Jiang H; Hish G; Zhang J; Chen YE; Jin JP; Xu J; Zhang K; Sun F
    PNAS Nexus; 2023 Jan; 2(1):pgac306. PubMed ID: 36712930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver disease in cystic fibrosis.
    Kobelska-Dubiel N; Klincewicz B; Cichy W
    Prz Gastroenterol; 2014; 9(3):136-41. PubMed ID: 25097709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis, Management, and Prognosis of Cystic Fibrosis-Related Liver Disease in Children.
    Anton-Păduraru DT; Azoicăi AN; Trofin F; Murgu AM; Mîndru DE; Bocec AS; Halițchi COI; Zota GR; Păduraru D; Nastase EV
    Diagnostics (Basel); 2024 Mar; 14(5):. PubMed ID: 38473009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced but not mild liver disease is a predictor of decreased survival in children with cystic fibrosis, with far greater impact in females: A 27-year real-life cohort study.
    Baldissera M; Lewindon PJ; Ramm LE; Hartel GF; Mattiello R; Ramm GA
    J Cyst Fibros; 2022 Mar; 21(2):230-235. PubMed ID: 34949555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population.
    Polineni D; Piccorelli AV; Hannah WB; Dalrymple SN; Pace RG; Durie PR; Ling SC; Knowles MR; Stonebraker JR
    PLoS One; 2018; 13(10):e0205257. PubMed ID: 30307979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystic fibrosis liver disease in Newfoundland and Labrador: a prevalence study.
    Squirell E; Lockyer J
    Can Liver J; 2021; 4(1):33-37. PubMed ID: 35991469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver disease in cystic fibrosis.
    Leeuwen L; Fitzgerald DA; Gaskin KJ
    Paediatr Respir Rev; 2014 Mar; 15(1):69-74. PubMed ID: 23769887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNAs as noninvasive diagnostic biomarkers of liver disease in children with cystic fibrosis.
    Cook NL; Pereira TN; Lewindon PJ; Shepherd RW; Ramm GA
    J Pediatr Gastroenterol Nutr; 2015 Feb; 60(2):247-54. PubMed ID: 25625579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis.
    Smith JL; Lewindon PJ; Hoskins AC; Pereira TN; Setchell KD; O'Connell NC; Shepherd RW; Ramm GA
    Hepatology; 2004 Jun; 39(6):1673-82. PubMed ID: 15185309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of patients with cystic fibrosis undergoing lung transplantation with and without cystic fibrosis-associated liver cirrhosis.
    Nash EF; Volling C; Gutierrez CA; Tullis E; Coonar A; McRae K; Keshavjee S; Singer LG; Durie PR; Chaparro C
    Clin Transplant; 2012; 26(1):34-41. PubMed ID: 21272072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.